Clinical trials: Obsessive Compulsive Disorder
Obsessive-Compulsive Disorder, Burns
OCD Among Patients With Burns
Estimating the prevalence of OCD symptoms among patients with burns
- Trial name
- NCT00294983
- Where
- Israel
- Sponsor
- Sheba Medical Center
Schizophrenia, Obsessive Compulsive Disorder
Chronic Schizophrenia With Obsessive-Compulsive Symptoms: Comorbidity or a Subtype?
Evaluating the prevalence and characteristics of obsessive-compulsive (OC) symptoms in patients with chronic schizophrenia
- Trial name
- NCT00269464
- Sponsor
- Sheba Medical Center
Obsessive Compulsive Disorder
Quetiapine Augmentation in Severe Obsessive Compulsive Disorder
The purpose of the study is to evaluate the efficacy of quetiapine or placebo added to baseline treatment of SSRI/clomipramine for the treatment of OCD in adult subjects.
- Trial name
- NCT00254735
- Testing
- quetiapine fumarate, SSRI/Clomipramine
- Where
- 2 sites in Germany
- Volunteers
- 44 people
- Sponsor
- AstraZeneca
Obsessive-Compulsive Disorder, Anxiety Disorders
Treatment for Anxiety in Children
The purpose of this study is to see if it is effective to treat children with anxiety disorders with fluvoxamine. Fluvoxamine has been successfully used to treat obsessive-compulsive disorder (OCD) in adults and children.
- Conditions
- Obsessive-Compulsive Disorder, Anxiety Disorders, Generalized Anxiety Disorder, Social Phobia
- Trial name
- NCT00000389
- Testing
- Fluvoxamine
- Sponsor
- National Institute of Mental Health (NIMH)
Neurotic Disorders, Obsessive-Compulsive Disorder
An Open-Label Study Of Lamictal In Neurotic Excoriation
The goal of the proposed study is to evaluate the efficacy and safety of Lamictal in neurotic excoriation. Twenty subjects with neurotic excoriation will receive 12 weeks of open-label treatment with Lamictal.
- Trial name
- NCT00269594
- Testing
- Lamictal (lamotrigine)
- Where
- United States
- Volunteers
- 25 people, healthy volunteers welcome
- Sponsor
- University of Minnesota
Obsessive Compulsive Disorder
Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD)
The purpose of this study is to assess the efficacy of Escitalopram in the treatment of obsessive compulsive disorder and to determine the optimal treatment dose.
- Trial name
- NCT00116532
- Testing
- Escitalopram
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Massachusetts General Hospital
Obsessive Compulsive Disorder
St. John's Wort Vs. Placebo in Obsessive-Compulsive Disorder.
The purpose of this study is to determine the effectiveness of St. John's Wort as compared to placebo (an inactive substance) in the treatment of outpatients with obsessive compulsive disorder.
- Trial name
- NCT00035438
- Testing
- St. John's Wort
- Where
- 2 sites in United States
- Volunteers
- 60 people
- Sponsor
- National Center for Complementary and Integrative Health (NCCIH)
Obsessive-Compulsive Disorder
Tolerability and Efficacy of High Dose Escitalopram for the Treatment of Obsessive-Compulsive Disorder (OCD)
Objectives: To evaluate tolerability and efficacy of escitalopram treatment in high dose than 20-50 mg/d in out-patients with OCD Type of the study: Open label, prospective study.
- Trial name
- NCT00305500
- Testing
- escitalopram
- Where
- Israel
- Volunteers
- 100 people
- Sponsor
- Abarbanel Mental Health Center
Obsessive-Compulsive Disorder
Phase II Randomized Study of Intravenous Versus Oral Clomipramine in Patients With Obsessive Compulsive Disorder
OBJECTIVES: I. Evaluate the efficacy of intravenous versus oral pulse loading of clomipramine (CMI) followed by a 12-week course of maintenance therapy in patients with obsessive compulsive disorder.
- Trial name
- NCT00004310
- Testing
- Clomipramine
- Where
- 2 sites in United States
- Volunteers
- 76 people
- Sponsor
- National Center for Research Resources (NCRR)
Tourette Syndrome, Obsessive Compulsive Disorder
Developmental Phenomenology of Obsessive Compulsive Disorder and Tourette Syndrome in Children and Adolescents
OBJECTIVES: I. Characterize the natural history, associated features, and severity of symptoms of obsessive compulsive disorder and Tourette syndrome in children and adolescents. II.
- Trial name
- NCT00004324
- Where
- United States
- Volunteers
- 90 people
- Sponsor
- National Center for Research Resources (NCRR)
Tourette Syndrome, Obsessive Compulsive Disorder
Study of the Neurobiology of Tourette Syndrome and Related Disorders
OBJECTIVES: I. Investigate the pathobiology of Tourette syndrome and related disorders by measuring various compounds of interest in cerebrospinal fluid, plasma, and urine of patients with Tourette syndrome, obsessive compulsive…
- Trial name
- NCT00004325
- Where
- United States
- Volunteers
- 200 people
- Sponsor
- National Center for Research Resources (NCRR)